Top Research Publications: June 2025

    Cardiovascular Medicine
    1. Brinker, L., Sideris, K., Wei, G., Singh, R., Nevers, M. R., Hartsell, S. E., Sarwal, A., Kyriakopoulos, C. P., Tseliou, E., Benes, J., Beddhu, S., & Stehlik, J. (2025). Diabetes Therapy With SGLT2i After Heart Transplant: A Multi-Institutional Analysis. Jacc Heart Failure, 13(8). https://doi.org/10.1016/j.jchf.2025.102520
       
    2. St. John, E., Carey, J. R., Wilcox, T., Ryan, J., Ramakrishna, S., Daud, A., Diaz-Robles, D., Smith, A., Cowan, K., & Wang, L. (2025). Expanding the Patient Pool for Rilonacept. Jacc Case Reports, 30(17). https://doi.org/10.1016/j.jaccas.2025.103799
       
    3. Shah, A. S., Engels, M., Freedman, R. A., Lehmann, I., Konstantinidis, K., Ranjan, R., & Bunch, T. J. (2025). Real-World Safety Profile of the Extravascular (EV) Implantable Defibrillator System: Insights From the MAUDE Database. Circulation Arrhythmia and Electrophysiology. https://doi.org/10.1161/CIRCEP.125.013831
       
    4. Scott, M., Kyriakopoulos, C. P., Sheffield, E., Krauspe, E., Sideris, K., Taleb, I., Maneta, E., Tseliou, E., Selko, S., Hamouche, R., Hanff, T. C., & Drakos, S. G. (2025). Application of the Updated Cardiogenic Shock Working Group SCAI Classification for Cardiogenic Shock: A Single-Centre Analysis. Canadian Journal of Cardiology. https://doi.org/10.1016/j.cjca.2025.03.036
       
    5. Majmudar, U. V., Stehlik, J., & Jorde, U. P. (2025). Pre-implant Patient Assessment and Optimization. In Management of Acute and Chronic Severe Heart Failure Advances in Mechanical Circulatory Support. https://doi.org/10.1007/978-3-031-74963-6_12
       
    6. Shah, A. R., Yazaki, K., Seamons, B., Offei, E., Castilo, S. R., Li, H., Khan, M. S., Hitchcock, R., Ranjan, R., & Dosdall, D. J. (2025). Multiple electrode leads facilitate left bundle branch area pacing: A concept evaluation study. Heart Rhythm O2. https://doi.org/10.1016/j.hroo.2025.04.012
    Epidemiology
    1. Zhou, R., Sullivan-Baca, E., Bart, T., Pugh, M. J., Towne, A., & Haneef, Z. (2025). Social determinants of health and healthcare utilization in veterans with post-traumatic epilepsy. Epilepsy Research, 216. https://doi.org/10.1016/j.eplepsyres.2025.107594
       
    2. Poon, E. G., Lemak, C. H., Rojas, J. C., Guptill, J., & Classen, D. (2025). Adoption of artificial intelligence in healthcare: Survey of health system priorities, successes, and challenges. Journal of the American Medical Informatics Association, 32(7), 1093–1100. https://doi.org/10.1093/jamia/ocaf065
       
    3. Medina, A., Sussman, J., Sosa, N., Valdez, M., Andrews, J. R., Croda, J., Sanabria, G. E., Sequera, G., Aguirre, S., & Walter, K. S. (2025). The concentration of tuberculosis within Paraguay’s Indigenous population, 2018–2022: a retrospective population-based study. Lancet Regional Health Americas, 47. https://doi.org/10.1016/j.lana.2025.101140
       
    4. Butler, J. M., Childs, E., Barlam, T., Drainoni, M.-L., Reardon, C., Zhang, Y., Damschroder, L., Taber, P., Madaras-Kelly, K., Goetz, M., Presson, A., & Samore, M. H. (2025). Assessing hospital antibiotic stewardship program (ASP) implementation: validation of an implementation science-informed survey. Antimicrobial Stewardship and Healthcare Epidemiology, 5(1). https://doi.org/10.1017/ash.2025.65
       
    5. Melhorn, J. M., Gelinas, B., Martin, D. W., Hegmann, K. T., & Thiese, M. S. (2025). Reliability and Methodological Advancements in the 2024 AMA Guides for Rating Lower Limb Impairment. Journal of the American Academy of Orthopaedic Surgeons Global Research and Reviews, 9(6). https://doi.org/10.5435/JAAOSGlobal-D-25-00072
       
    6. Kim, J., Lee, S., & Weir, P. (2025). Long-COVID is associated with increased absenteeism from work. Plos One, 20(6 JUNE). https://doi.org/10.1371/journal.pone.0325280
       
    7. Riley, T. R., Wheeler, A. M., Cannon, G. W., Sauer, B., Wysham, K. D., England, B. R., Wipfler, K., Michaud, K., March, M., Damrauer, S. M., Mikuls, T. R., & Baker, J. F. (2025). Genetically-determined variation in CRP impacts disease activity assessment in rheumatoid arthritis. Rheumatology, 64(6), 3921–3928. https://doi.org/10.1093/rheumatology/keaf069
       
    8. Vanneman, M. E., Roberts, E. T., Li, Y., Sileanu, F. E., Essien, U. R., Mor, M. K., Fine, M. J., Thorpe, C. T., Radomski, T. R., Suda, K. J., Suda, K. J., & Gellad, W. F. (2025). Experiences With VA-Purchased Community Care for US Veterans With Mental Health Conditions. JAMA Network Open, 8(5). https://doi.org/10.1001/jamanetworkopen.2025.11548
       
    9. Choi, Y., Heller, E., Amoafo, L., Zhang, Y., Miller, K., Loveridge, A., Ruggieri, M., Gesteland, P., & Ampofo, K. (2025). Readmission Following Respiratory Syncytial Virus Hospitalization among Children <5 Years of Age. Journal of the Pediatric Infectious Diseases Society, 14(5). https://doi.org/10.1093/jpids/piaf036
       
    10. Liang, S., Huang, E., Stout, J., Winterton, C., Zhang, C., Dorsey, B. F., Presson, A., Firpo, M., & Park, A. (2025). Comparison of Hearing Phenotypes Among Children With Congenital Cytomegalovirus and Other Non-Cytomegalovirus Conditions. Oto Open, 9(2). https://doi.org/10.1002/oto2.70087
       
    11. Kelley, A. T., Yoo, M., Suo, Y., Nelson, R. E., Gordon, A. J., & Jones, A. L. (2025). Changes in healthcare utilization and costs following enrollment in an interprofessional primary care clinic designed to address clinical and social vulnerabilities. Journal of Interprofessional Care. https://doi.org/10.1080/13561820.2025.2507968
       
    12. Tuteja, S., O’Brien, W. J., Ferraro, J. P., Damrauer, S. M., Itani, K. M. F., Voight, B. F., Teerlink, C. C., Lynch, J. A., Duvall, S. L., Strebel, T., Wilson, M. A., & Barrett, T. W. (2025). Drug-Gene Interactions and Clinical Outcomes after Vascular Surgery in the Million Veteran Program. JAMA Surgery. https://doi.org/10.1001/jamasurg.2025.1503
       
    13. Siantz, E., Cabassa, L. J., & Gordon, A. J. (2025). Promoting Health Equity Among People With Opioid Use Disorder and Serious Mental Illness Through the Chronic Disease Self-Management Program. Substance Use Research and Treatment, 19. https://doi.org/10.1177/29768357251342749
       
    14. Madison, C. J., Lynch, J. A., Duvall, S. L., Alba, P. R., Hanchrow, E., Agiri, F. Y., Pridgen, K. M., Burri, R. J., Thompson, R. F., Kelly, M., Kelly, M., & Katsoulakis, E. (2025). Development and Validation of a Computable Radiation Therapy Phenotype. International Journal of Radiation Oncology Biology Physics. https://doi.org/10.1016/j.ijrobp.2025.05.001
       
    15. Codden, R. R., Ofori-Atta, B. S., Carter, M. E., Herget, K. A., Doherty, J. A., Kirchhoff, A. C., & Millar, M. M. (2025). Factors associated with cancer-related pain among Utah cancer survivors. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-025-01840-2
       
    16. D’alonzo, B. A., Schneider, A. L. C., Erz, A., Master, C. L., Barnett, I. J., Hamilton, R. H., Wiebe, D. J., & Szymczak, J. E. (2025). A Qualitative Study of Collegiate Student-Athlete Experiences of Recovery After Concussion. Journal of Head Trauma Rehabilitation. https://doi.org/10.1097/HTR.0000000000001067
       
    17. Chanfreau-Coffinier, C., Friede, K. A., Plomondon, M. E., Lee, K. M., Lu, Z., Dinatale, T., DuVall, S. L., Vassy, J. L., Waldo, S. W., Cleator, J. H., Giri, J., & Tuteja, S. (2025). CYP2C19 Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention in the Million Veteran Program. Clinical Pharmacology and Therapeutics. https://doi.org/10.1002/cpt.3741
       
    18. Nugent, S. M., Hooker, E. R., Slatore, C., Winchell, K., Rubim, F., Rounsavill, T., Clayburgh, D., Knight, S., & Morasco, B. J. (2025). Associations between substance use, quality of life, and pain among Veteran survivors of head and neck cancer. Journal of Psychosocial Oncology. https://doi.org/10.1080/07347332.2025.2497410
       
    19. Jawish, R., Shangraw, K., Charles, J. E., Eddington, B., Worden, J., Tak, C., Mickey, B. J., Gordon, A. J., & Smid, M. C. (2025). Interest in Transcranial Magnetic Stimulation Therapy for Treatment of Depression and Substance Use Disorder Among Peripartum Individuals. Journal of Addiction Medicine. https://doi.org/10.1097/ADM.0000000000001524
       
    20. Scott, M., Kyriakopoulos, C. P., Sheffield, E., Krauspe, E., Sideris, K., Taleb, I., Maneta, E., Tseliou, E., Selko, S., Hamouche, R., Hanff, T. C., & Drakos, S. G. (2025). Application of the Updated Cardiogenic Shock Working Group SCAI Classification for Cardiogenic Shock: A Single-Centre Analysis. Canadian Journal of Cardiology. https://doi.org/10.1016/j.cjca.2025.03.036
       
    21. Rostam-Abadi, Y., Liebschutz, J. M., Subramaniam, G., Stone, R., Appleton, N., Mazel, S., Alexander, K., Brill, S. B., Case, A., Gelberg, L., Zhang, S., & McNeely, J. (2025). Understanding the characteristics and comorbidities of primary care patients with risky opioid use: Baseline data from the multi-site “Subthreshold Opioid Use Disorder Prevention” (STOP) Trial. Journal of General Internal Medicine. https://doi.org/10.1007/s11606-025-09613-4
       
    22. Patel, S. S., Raman, V. K., Zhang, S., Sheriff, H. M., Fonarow, G. C., Heidenreich, P. A., Faselis, C., Lam, P. H., Morgan, C. J., Moore, H., Zeng-Treitler, Q., & Ahmed, A. (2025). Renin Angiotensin Inhibition and Lower Risk of Kidney Failure in Patients with Heart Failure. American Journal of Medicine. https://doi.org/10.1016/j.amjmed.2025.04.038
       
    23. Chen, J. I., Niederhausen, M., Bui, D. P., Govier, D. J., Rowneki, M., Hickok, A., Shahoumian, T. A., Shepherd-Banigan, M., Korpak, A., Hawkins, E., Wong, E., & Wyatt, K. (2025). Veteran Mental Health Emergency Care Utilization Following SARS-CoV-2 Infection. Health Services Research. https://doi.org/10.1111/1475-6773.14622
    Endocrinology

    No publications this month. Check back next month for updates.

    Gastroenterology, Hepatology, and Nutrition
    1. Diehl, G., Archibald, Z. G., Gingrich, K., Ballance, A. T., Buckway, B., Shumaker-Parry, J. S., Yap, J. T., Zharov, I., & Mastren, T. (2025). Theranostic nanoparticles: Investigation of superparamagnetic iron oxide nanoparticles intrinsically labeled with Zirconium-89 and Actinium-225. Nuclear Medicine and Biology, 146–147. https://doi.org/10.1016/j.nucmedbio.2025.109045
       
    2. Mitselou, N., Uchida, A., Roelstraete, B., Melén, E., Garber, J. J., & Ludvigsson, J. F. (2025). Risk of asthma in individuals with eosinophilic esophagitis: Population-based cohort study with sibling analyses. Clinical and Translational Allergy, 15(6). https://doi.org/10.1002/clt2.70068
       
    3. Vainer, D., & Peterson, K. (2025). Non allergic gastrointestinal manifestations of hereditary alpha-tryptasemia. Frontiers in Allergy, 6. https://doi.org/10.3389/falgy.2025.1598309
       
    4. Maniaci, J. L., Iuga, A., Bookhout, C. E., Cortright, L. M., Walker, K. B., Moist, S. E., Peterson, K. A., Mitlyng, B. L., & Dellon, E. S. (2025). Mepolizumab Improves Histologic Severity as Measured by the EoEHSS in Adolescents and Adults With Eosinophilic Oesophagitis in a Multicenter, Randomised, Double-Blind, Placebo-Controlled Clinical Trial. Alimentary Pharmacology and Therapeutics. https://doi.org/10.1111/apt.70216
    General Internal Medicine
    1. Kay, A. B., Woller, S. C., Groat, D., Regner, J. L., Schroeppel, T. J., Fontaine, G. V., & Majercik, S. (2025). Use of post-discharge venous thromboembolism prophylaxis in hospitalized trauma patients – survey results of Southwestern surgical Congress and Southeastern surgical Congress members. American Journal of Surgery, 250. https://doi.org/10.1016/j.amjsurg.2025.116491
       
    2. Gordon, L., Shaffer, K., Finn, G., Lamb, S., Brown, M., & Chow, C. (2025). The Unique Possibilities of Longitudinal Qualitative Research in Health Professions Education. Clinical Teacher, 22(4). https://doi.org/10.1111/tct.70126
       
    3. Williamson, A. J. H., Leonard, M., Weiss, R., Kaphingst, K. A., Supiano, M. A., & Cohan, J. N. (2025). The surgeon’s role in optimizing elective surgical care for older adults: Perspectives of outpatient geriatricians. Current Problems in Surgery, 68. https://doi.org/10.1016/j.cpsurg.2025.101764
       
    4. Klok, F. A., Woller, S. C., Schwartz, A., Mishra, S., Angchaisuksiri, P., Bayley, J., Habert, J., Hernandez-Nino, J., Hunter, R., Kline, J. A., de Wit, K., & le Gal, G. (2025). Optimising communication to patients with venous thromboembolism: development of a provider toolkit. Lancet Haematology, 12(6), e411–e412. https://doi.org/10.1016/S2352-3026(25)00136-X
       
    5. Liu, C., Chow, S.-M., Aris, I. M., Dabelea, D., Neiderhiser, J. M., Leve, L. D., Blair, C., Catellier, D. J., Couzens, L., Braun, J. M., Hockett, C. W., & Ganiban, J. M. (2025). Early-Life Factors and Body Mass Index Trajectories Among Children in the ECHO Cohort. JAMA Network Open, 8(5). https://doi.org/10.1001/jamanetworkopen.2025.11835
       
    6. Glasgow, M., Whipple, M., & Drum, B. M. (2025). Pneumocystis Pneumonia and Hypercalcemia: An Underrecognized and Atypical Feature of a Common Opportunistic Infection. Annals of Internal Medicine Clinical Cases, 4(5). https://doi.org/10.7326/aimcc.2024.0960
       
    7. Harris, K., Schardein, J., Kundrat, K., & Low, C. (2025). Genitourinary Symptoms of Menopause in Patients with Serious Illness #511. Journal of Palliative Medicine. https://doi.org/10.1089/jpm.2025.0270
       
    8. Kelley, A. T., Yoo, M., Suo, Y., Nelson, R. E., Gordon, A. J., & Jones, A. L. (2025). Changes in healthcare utilization and costs following enrollment in an interprofessional primary care clinic designed to address clinical and social vulnerabilities. Journal of Interprofessional Care. https://doi.org/10.1080/13561820.2025.2507968
       
    9. Rostam-Abadi, Y., Liebschutz, J. M., Subramaniam, G., Stone, R., Appleton, N., Mazel, S., Alexander, K., Brill, S. B., Case, A., Gelberg, L., Zhang, S., & McNeely, J. (2025). Understanding the characteristics and comorbidities of primary care patients with risky opioid use: Baseline data from the multi-site “Subthreshold Opioid Use Disorder Prevention” (STOP) Trial. Journal of General Internal Medicine. https://doi.org/10.1007/s11606-025-09613-4
       
    10. Zhong, L., Bather, J. R., Goodman, M. S., Kaiser-Jackson, L., Volkmar, M., Bradshaw, R. L., Lorenz Chambers, R., Chavez-Yenter, D., Colonna, S. V., Maxwell, W., Buys, S. S., & Kaphingst, K. A. (2025). Importance of Prior Patient Interactions With the Healthcare System to Engaging With Pretest Cancer Genetic Services via Digital Health Tools Among Unaffected Primary Care Patients: Findings From the BRIDGE Trial. Health Services Research. https://doi.org/10.1111/1475-6773.14652
    Geriatrics
    1. Cho, M. E., Brunt, V. E., Shiu, Y.-T., & Bunsawat, K. (2025). Endothelial dysfunction in chronic kidney disease: a clinical perspective. American Journal of Physiology Heart and Circulatory Physiology, 329(1), H135–H153. https://doi.org/10.1152/ajpheart.00908.2024
       
    2. Williamson, A. J. H., Leonard, M., Weiss, R., Kaphingst, K. A., Supiano, M. A., & Cohan, J. N. (2025). The surgeon’s role in optimizing elective surgical care for older adults: Perspectives of outpatient geriatricians. Current Problems in Surgery, 68. https://doi.org/10.1016/j.cpsurg.2025.101764
       
    3. Butler, J. M., Childs, E., Barlam, T., Drainoni, M.-L., Reardon, C., Zhang, Y., Damschroder, L., Taber, P., Madaras-Kelly, K., Goetz, M., Presson, A., & Samore, M. H. (2025). Assessing hospital antibiotic stewardship program (ASP) implementation: validation of an implementation science-informed survey. Antimicrobial Stewardship and Healthcare Epidemiology, 5(1). https://doi.org/10.1017/ash.2025.65
       
    4. Gimblet, C. J., Donato, A. J., Jalal, D. I., & Pierce, G. L. (2025). Sex differences in endothelial glycocalyx thickness and the response to glycocalyx-targeted therapy among older adults. Physiological Reports, 13(12). https://doi.org/10.14814/phy2.70428
       
    5. Kozlova, D., Gimblet, C., Wendt, L., Akbari, S., Taiwo, A., Dayal, S., Eyck, P. T., Stanhewicz, A., Trinity, J., & Jalal, D. (2025). Vascular dysfunction is associated with major adverse cardiovascular events in prediabetes: A cohort study. Plos One, 20(6 JUNE). https://doi.org/10.1371/journal.pone.0324945
    Hematology and Hematologic Malignancies
    1. St-Pierre, F., Bhatta, S., Doukas, P. G., Jenkin, M., Annunzio, K., Rojek, A. E., Gibson, A., Tiger, Y. K., McCall, B., Alhamad, K., Karmali, R., & Epperla, N. (2025). Impact of extranodal involvement at CAR T-cell therapy on outcomes in patients with relapsed or refractory large B-cell lymphoma—Results from a multicenter cohort study. Blood Cancer Journal, 15(1). https://doi.org/10.1038/s41408-025-01318-5
       
    2. Zanti, M., O’Mahony, D. G., Parsons, M. T., Dorling, L., Dennis, J., Boddicker, N. J., Chen, W., Hu, C., Naven, M., Yiangou, K., Spurdle, A. B., & Michailidou, K. (2025). Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification. Nature Communications, 16(1). https://doi.org/10.1038/s41467-025-59979-6
       
    3. Cogan, J. C., Burnett, A. E., Power-Hays, A., Barnes, G. D., & Lim, M. Y. (2025). Identifying and addressing underuse in hematologic care through systems-based hematology. Research and Practice in Thrombosis and Haemostasis, 9(4). https://doi.org/10.1016/j.rpth.2025.102881
       
    4. Mohyuddin, G. R., & Goodman, A. M. (2025). Daratumumab and missed sequencing opportunities in transplant-ineligible multiple myeloma: lessons for future trials. Nature Reviews Clinical Oncology. https://doi.org/10.1038/s41571-025-01034-w
       
    5. Epperla, N., Lucero, M., Bailey, T., Mirams, L., Cheung, J., Amet, M., Milligan, G., & Chen, L. (2025). How well does loncastuximab tesirine work after chimeric antigen receptor T-cell treatment in diffuse large B-cell lymphoma? A plain language summary of a real-world evidence study. Future Oncology, 21(15), 1827–1836. https://doi.org/10.1080/14796694.2025.2504802
       
    6. Cappelli, L., Kayne, A., Newman, J., Elguindy, A., Epperla, N., Palmer, J. D., Outschoorn, U. M., Porcu, P., Shi, W., & Alnahhas, I. (2025). Primary central nervous system lymphoma: Predictors of response to induction therapy and patterns of progression. Neuro Oncology Advances, 7(1). https://doi.org/10.1093/noajnl/vdaf082
       
    7. Arellano, N. S., Heaton, W. L., Nauman, M. C., Runnels, A. E., Gomez-Villa, J., Vanni, D., Gaviria, M., Fujita, M., Krah, N. M., Ciboddo, M., Saygin, C., & Elf, S. E. (2025). Type 2 calreticulin mutations activate ATF6 to promote BCL-xL–mediated survival in myeloproliferative neoplasms. Blood. https://doi.org/10.1182/blood.2024026940
       
    8. Stephens, D. M., Stewart, C., Avruch, L., Coombs, C. C., Danilov, A., Hill, B., Shadman, M., Gerrie, A., Jensen, C. E., Hoffmann, M., Koffman, B., & Byrd, J. C. (2025). Feasibility of Bruton’s Tyrosine Kinase Inhibitor Discontinuation in Chronic Lymphocytic Leukemia: The Patient Perspective. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2025.05.011
       
    9. Arellano, M. L., Thirman, M. J., DiPersio, J. F., Heiblig, M., Stein, E. M., Schuh, A. C., Žučenka, A., de Botton, S., Grove, C. S., Mannis, G. N., Smith, A. R., & Blachly, J. S. (2025). Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study. Blood. https://doi.org/10.1182/blood.2025028357
    Infectious Diseases
    1. Fenlon, J., van Bibber, N., Mahlow, J., Yamoah, K., Soupir, A. C., Nguyen, J. V., Segura, C. M., Spivak, A. M., Knudsen, B. S., Zhou, Q., Suneja, G., & Coghill, A. E. (2025). Human Immunodeficiency Virus-Associated Differences in the Tumor Immune Microenvironment of Lung, Breast, and Prostate Cancers. Cancer Epidemiology Biomarkers and Prevention, 34(6), 860–867. https://doi.org/10.1158/1055-9965.EPI-24-1421
       
    2. Redmond, S. N., Cadnum, J. L., Jencson, A. L., Kaple, C. E., Wilson, B. M., Skinner, A. M., Gargis, A. S., Hwang, M., Choi, H., Chatterjee, P., Jinadatha, C., & Donskey, C. J. (2025). Emergence and Spread of Clostridioides difficile Isolates With Reduced Fidaxomicin Susceptibility in an Acute Care Hospital. Clinical Infectious Diseases, 80(5), 984–991. https://doi.org/10.1093/cid/ciaf028
       
    3. Williams, S. L., Benedict, K., Jackson, B. R., Rajeev, M., Cooksey, G., Ruberto, I., Williamson, T., Sunenshine, R. H., Osborn, B., Oltean, H. N., Chiller, T., & Toda, M. (2025). Estimated Burden of Coccidioidomycosis. JAMA Network Open, e2513572. https://doi.org/10.1001/jamanetworkopen.2025.13572
    Nephrology and Hypertension
    1. Brinker, L., Sideris, K., Wei, G., Singh, R., Nevers, M. R., Hartsell, S. E., Sarwal, A., Kyriakopoulos, C. P., Tseliou, E., Benes, J., Beddhu, S., & Stehlik, J. (2025). Diabetes Therapy With SGLT2i After Heart Transplant: A Multi-Institutional Analysis. Jacc Heart Failure, 13(8). https://doi.org/10.1016/j.jchf.2025.102520
       
    2. Cho, M. E., Brunt, V. E., Shiu, Y.-T., & Bunsawat, K. (2025). Endothelial dysfunction in chronic kidney disease: a clinical perspective. American Journal of Physiology Heart and Circulatory Physiology, 329(1), H135–H153. https://doi.org/10.1152/ajpheart.00908.2024
       
    3. Opurum, P. C., Decker, S. T., Stuart, D., Peterlin, A. D., Paula, V. L., Siripoksup, P., Drummond, M. J., Sanchez, A., Ramkumar, N., & Funai, K. (2025). Combined sedentarism and high-fat diet induce early signs of kidney injury in C57BL/6J mice. American Journal of Physiology Renal Physiology, 328(6), F850–F860. https://doi.org/10.1152/ajprenal.00259.2024
       
    4. Yamauchi, J., Fornadi, K., Raghavan, D., Jweehan, D., Oygen, S., Marineci, S., Buff, M., Fenlon, M., Selim, M., Zimmerman, M., Zimmerman, M., & Molnar, M. Z. (2025). Development of BK polyomavirus-associated nephropathy risk prediction in kidney transplant recipients. Renal Failure, 47(1). https://doi.org/10.1080/0886022X.2025.2509785
    Oncology
    1. Sukrithan, V., Ahmed, U., Krause, H., Gandhi, N., Elliott, A., Hinton, A., Walker, P., Vanderwalde, A., Zhou, Y., Patel, D. C., Rogers, K. A., & Konda, B. (2025). Targeting anti-apoptosis as a therapeutic strategy in neuroendocrine neoplasms. Endocrine Related Cancer, 32(7). https://doi.org/10.1530/ERC-24-0341
       
    2. Swami, U., Jo, Y., Narang, A., Plets, M., Hage Chehade, C., Gebrael, G., Gupta, S., Myint, Z., Tangen, C., Lara, P. N., Lerner, S. P., & Agarwal, N. (2025). Correlation of Body Mass Index with Overall Survival Among Patients with Metastatic Hormone-sensitive Prostate Cancer: Analysis of Patient-level Data from SWOG-1216. European Urology Oncology, 8(3), 612–615. https://doi.org/10.1016/j.euo.2024.10.013
       
    3. Fenlon, J., van Bibber, N., Mahlow, J., Yamoah, K., Soupir, A. C., Nguyen, J. V., Segura, C. M., Spivak, A. M., Knudsen, B. S., Zhou, Q., Suneja, G., & Coghill, A. E. (2025). Human Immunodeficiency Virus-Associated Differences in the Tumor Immune Microenvironment of Lung, Breast, and Prostate Cancers. Cancer Epidemiology Biomarkers and Prevention, 34(6), 860–867. https://doi.org/10.1158/1055-9965.EPI-24-1421
       
    4. Lagos, G., Groisberg, R., Elliott, A., Dizon, D. S., Seeber, A., Gibney, G. T., von Mehren, M., Cardona, K., Demeure, M. J., Riedel, R. F., DeNardo, B., & Trent, J. C. (2025). Large-Scale Multiomic Analysis Identifies Anatomic Differences and Immunogenic Potential in Subtypes of Leiomyosarcoma. Clinical Cancer Research, 31(11), 2210–2221. https://doi.org/10.1158/1078-0432.CCR-24-2503
       
    5. Vobugari, N., Makovec, A., Kellen, S., Nazari, S. S., Elliott, A., Schmeck, D., Deacon, A., von Dohlen, G., John, E., Barata, P. C., Antonarakis, E. S., & Hwang, J. (2025). HSD3B1 (c.1100C) Genotype Is Associated with Distinct Tumoral and Clinical Outcomes in Breast and Endometrial Cancers. International Journal of Molecular Sciences, 26(12). https://doi.org/10.3390/ijms26125720|
       
    6. Gupta, S., Loriot, Y., van der Heijden, M. S., Bedke, J., Valderrama, B. P., Kikuchi, E., Fléchon, A., Petrylak, D., de Santis, M., Galsky, M. D., McManus, S., & Powles, T. (2025). Enfortumab vedotin plus pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial cancer (EV-302): patient-reported outcomes from an open-label, randomised, controlled, phase 3 study. Lancet Oncology, 26(6), 795–805. https://doi.org/10.1016/S1470-2045(25)00158-5
       
    7. Riely, G. J., Wood, D. E., Loo, B. W., Aisner, D. L., Akerley, W., Bauman, J. R., Bharat, A., Chang, J. Y., Chirieac, L. R., DeCamp, M., Gregory, K., & Hang, L. (2025). Thymomas and Thymic Carcinomas, Version 2.2025. Jnccn Journal of the National Comprehensive Cancer Network, 23(6), 255–269. https://doi.org/10.6004/jnccn.2025.0027
       
    8. Wolf, D. M., Yau, C., Campbell, M., Glas, A., Barcaru, A., Mittempergher, L., Kuilman, M., Brown-Swigart, L., Hirst, G., Basu, A., Khan, Q., & Edmiston, K. K. (2025). Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 Trial. JCO Precision Oncology, 9. https://doi.org/10.1200/PO-24-00776
       
    9. Ostrowski, M., Gebrael, G., & Maughan, B. L. (2025). Metastatic renal cell carcinoma disease response in the era of immune checkpoint inhibitor-based combinations. Translational Andrology and Urology, 14(5), 1169–1173. https://doi.org/10.21037/tau-2025-93
       
    10. Galarza Fortuna, G. M., Swami, U., & Gupta, S. (2025). Response to: Comment on “Nivolumab adjuvant to chemo-radiation in localized muscle-invasive urothelial cancer: primary analysis of a multicenter, single-arm, phase II, investigator-initiated trial (NEXT).” Journal for Immunotherapy of Cancer, 13(5). https://doi.org/10.1136/jitc-2025-012378
       
    11. Zhong, L., Bather, J. R., Goodman, M. S., Kaiser-Jackson, L., Volkmar, M., Bradshaw, R. L., Lorenz Chambers, R., Chavez-Yenter, D., Colonna, S. V., Maxwell, W., Buys, S. S., & Kaphingst, K. A. (2025). Importance of Prior Patient Interactions With the Healthcare System to Engaging With Pretest Cancer Genetic Services via Digital Health Tools Among Unaffected Primary Care Patients: Findings From the BRIDGE Trial. Health Services Research. https://doi.org/10.1111/1475-6773.14652
       
    12. Najjar, Y. G., Orloff, M., Mitchell, T. C., Bowles, T. L., Betof Warner, A., Bollin, K., Chandra, S., Cohen, J. V., Eroglu, Z., Funchain, P., Guild, S., & Patel, S. P. (2025). Proceedings of the seventh annual Women in Melanoma Conference. Therapeutic Advances in Medical Oncology, 17. https://doi.org/10.1177/17588359251342039
       
    13. Perez, K., del Rivero, J., Kennedy, E. B., Basu, S., Chauhan, A., Connolly, H. M., Dasari, A. N., Gangi, A., Clarke, C. N., Hallet, J., Strosberg, J. R., & Bergsland, E. K. (2025). Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline. JCO Oncology Practice. https://doi.org/10.1200/OP-25-00133
    Pulmonary Medicine
    1. Aoki, J. A., Denorme, F., Cody, M. J., Perry, D. P., Rustad, J. L., Brown, S. M., Goldstein, S. A., Middleton, E. A., Yost, C. C., & Harris, E. S. (2025). Plasma surrogate markers of neutrophil extracellular traps correlate with disease severity in patients with moderate to severe acute respiratory distress syndrome. Journal of Inflammation United Kingdom, 22(1). https://doi.org/10.1186/s12950-025-00448-8
       
    2. Carr, J. R., Locke, B., Patel, J. J., Peltan, I. D., Brown, S. M., Bosch, N. A., & Law, A. C. (2025). Use of High-Dose Hydroxocobalamin for Septic Shock. Chest, 168(1), 131–135. https://doi.org/10.1016/j.chest.2025.01.016
       
    3. Patel, J. J., Carr, J., & Willoughby, R. (2025). Biologic rationale and evidence for high-dose hydroxocobalamin in septic shock. Current Opinion in Critical Care. https://doi.org/10.1097/MCC.0000000000001289
       
    4. Lim, M. J., Whitney, J. E., Sallee, C. J., Markovic, D., Bera, A., Sinha, P., Zeigler, A., Chen, L., Zinter, M. S., Ali, A., McKenzie, A., & Villarreal-Chico, D. (2025). Plasma Soluble Intercellular Adhesion Molecule-1 Has a Central Role in Biomarker Network Analysis and Is Associated With Poor Outcomes in Two Distinct Pediatric Cohorts of Acute Respiratory Distress Syndrome and Acute Respiratory Failure. Critical Care Medicine. https://doi.org/10.1097/CCM.0000000000006719
    Rheumatology
    1. Brikman, S., Perets, O., Serfaty, L., Abuhasira, R., Schlesinger, N., Ayalon, S., Bieber, A., & Rappoport, N. (2025). Incidence of gout diagnosis among participants with hyperuricemia, insights from a nationwide cohort study. Seminars in Arthritis and Rheumatism, 74. https://doi.org/10.1016/j.semarthrit.2025.152764
       
    2. Reid, J. M., Miller, K. L., Oliver, B., Swee, M., & Wilson, J. R. (2025). Enhancing Drug Hypersensitivity Reaction Documentation Through a Clinical Surveillance Tool. Journal for Healthcare Quality. https://doi.org/10.1097/JHQ.0000000000000481
       
    3. Sathapanasiri, T., Meraz, M., Mokri, H., Veettil, S., Wijarnpreecha, K., Schlesinger, N., Kavanaugh, A., & Chaiyakunapruk, N. (2025). Gastrointestinal perforation as a safety concern among patients with rheumatoid arthritis on Janus kinase inhibitor therapy: A systematic review and network meta-analysis. Arthritis Care and Research. https://doi.org/10.1002/acr.25554